Skip to main content Skip to main navigation menu Skip to site footer

Comparison of TLR2/1, NF-кB p105/50, NF-кB p65, and TNF-α expressions in the macrophages between multibacillary leprosy patients with and without erythema nodosum leprosum signifying innate immune system activity

  • M Yulianto Listiawan ,
  • Cita Rosita Sigit Prakoeswa ,
  • Indropo Agusni ,


Background: Erythema nodosum leprosum (ENL) is one of the complications in multibacillary (MB) leprosy. The cause, mechanism, and treatment of ENL remain highly problematic. Various studies have identified possible involvement of the innate immune system in the pathogenesis of ENL. Increased understanding of this mechanisms maybe useful for the management of leprosy.

Objective: To compare the expression of Toll-like Receptor-2/1 (TLR2/1), Nuclear Factor Kapha Beta (NF-кB) p105/p50, NF-кB p65, Tumor Necrosis Factor-α (TNF-α) in the macrophages of MB patients with and without ENL as a marker of innate immune system involvement.

Methods:  This study is a cross-sectional study performed on 42 MB leprosy patients (21 with ENL and 21 without ENL) in the outpatient unit of Dr. Soetomo General Hospital from February to December 2010. Immunohistochemical staining method was conducted on all groups to determine the expression in macrophages of the dermis using the specific monoclonal antibody for TLR2/1, NF-кBp105/p50, NF-кBp65, and TNF-α. Statistical analysis was performed using Mann-Whitney U test.

Result: There was a significant difference of TLR2/1, NF-кBp105/p50, NF-кBp65, and TNF-α expression in the dermis macrophages between the MB leprosy patients with ENL and without ENL.

Conclusion: The innate immunity was activated in the ENL reaction of MB leprosy.


  1. Abulafia J, Vignale RA. Leprosy: pathogenesis updated. International journal of dermatology. 1999;38(5):321-34.
  2. Rea TH MR. Leprosy. Freedberg IM EA, Wolff K, Austeen KF, Goldsmith IA, Katz SI, editor2003.
  3. Manandhar R, LeMaster JW, Roche PW. Risk factors for erythema nodosum leprosum. Int J Lepr Other Mycobact Dis. 1999;67(3):270-8.
  4. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clinical microbiology reviews. 2006;19(2):338-81.
  5. Abbas AK LA, Pilai S. Cellular and Molecular Immunology (6th Edition). Beijing: Sounders Elsevier; 2007.
  6. Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL. Tumor necrosis factor production in patients with leprosy. Infection and immunity. 1992;60(4):1441-6.
  7. Kaur I, Agnihotri N, Mehta M, Dogra S, Ganguly NK. Tumor necrosis factor (TNF) production in leprosy patients. Int J Lepr Other Mycobact Dis. 2001;69(3):249-50.
  8. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine. 2002;20(2):56-62.
  9. Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. Journal of immunology. 2003;170(7):3451-4.
  10. Sehgal IN BS, Chattopadhaya, Saha K. Tumor Necrosis Factor: Status in reaction in leprosy before and after treatment. Int J Dermatol. 1993;32:436-9.
  11. Murphy K TP, Walpart M. Janeway’s Immunobiology (7th ed). New York: Garland Science; 2008.
  12. Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A, et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nature medicine. 2003;9(5):525-32.
  13. Tripathi P AA. NF-🙵B Transcription Factor: A Key Player in The Generation of Immune Response. Current Science. 2006;90(4):519-31.
  14. Hagge DA, Ray NA, Krahenbuhl JL, Adams LB. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages. Journal of immunology. 2004;172(12):7771-9.
  15. Madhzitov R JCJ. Innate Immunity. The New England Journal of Medicine. 2000.
  16. Jopling WH. Leprosy reaction (reactional states). India: CBS Publisher & distributors; 1996.
  17. Caamano J, Hunter CA. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical microbiology reviews. 2002;15(3):414-29.
  18. Reber L, Vermeulen L, Haegeman G, Frossard N. Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PloS one. 2009;4(2):e4393.
  19. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-кB as Potential Biomarker for Oxidative Stress. British Journal of Nutrition. 2001;86(Suppl 1): S121 – S7.
  20. Darmaputra IGN, Herwanto N, Rusyati LM, Riawan W, Endaryanto A, Prakoeswa CRS. Distribution of iNOS expressions and TNF neutrophil cells as well as PGE2 and S100 Schwann cell dermal nerves in the erythema nodosum leprosum patients. Bali Medical Journal. 2018; 7(1): 262-266. DOI:10.15562/bmj.v7i1.879
  21. Santos DO CH, Buorguignon SC, Bastos OM, Rodrigues CR, van Heuverswyn H, Nery JA, Miranda A. Expression of B7-1 Costimulatory Molecules in Patient with Multibacillary Leprosy and Reactional States. Clinical and experimental dermatology. 2006;32:75-80.
  22. Abbas AK LA. Basic Immunology (3rd ed). Beijing: Sounders Elsevier; 2011.

How to Cite

Listiawan, M. Y., Cita Rosita Sigit Prakoeswa, & Indropo Agusni. (2019). Comparison of TLR2/1, NF-кB p105/50, NF-кB p65, and TNF-α expressions in the macrophages between multibacillary leprosy patients with and without erythema nodosum leprosum signifying innate immune system activity. Bali Medical Journal, 8(1), 347–353.




Search Panel

M Yulianto Listiawan
Google Scholar
BMJ Journal

Cita Rosita Sigit Prakoeswa
Google Scholar
BMJ Journal

Indropo Agusni
Google Scholar
BMJ Journal